Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and Cholestasis

rosiglitazone has been researched along with Cholestasis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S1
Chen, Y; Duan, Y; Han, J; Liu, L; Yang, S; Yang, X; Zhang, S1
Ao, JP; Li, HH; Li, YS; Lv, X; Song, JG; Song, SL; Wang, XR; Zhang, P1
Azar, R; Banner, B; Bird, S; Bonkovsky, HL; Szabo, G1

Other Studies

4 other study(ies) available for rosiglitazone and Cholestasis

ArticleYear
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors

2012
A novel therapy for hepatic cholestasis treatment-the combination of rosiglitazone and fenofibrate.
    European journal of pharmacology, 2023, Jan-05, Volume: 938

    Topics: Animals; Cholestasis; Fenofibrate; Liver; Mice; Mice, Inbred C57BL; Necrosis; Rosiglitazone; Ursodeoxycholic Acid

2023
Decreased hepatic peroxisome proliferator-activated receptor-γ contributes to increased sensitivity to endotoxin in obstructive jaundice.
    World journal of gastroenterology, 2011, Dec-28, Volume: 17, Issue:48

    Topics: Alanine Transaminase; Animals; Bile Ducts; Cholestasis; Endotoxemia; Endotoxins; Hypoglycemic Agents; Interleukin-1; Interleukin-6; Jaundice, Obstructive; Ligation; Liver; Male; Peroxisomes; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Survival Rate; Thiazolidinediones; Tumor Necrosis Factor-alpha

2011
Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone.
    Digestive diseases and sciences, 2002, Volume: 47, Issue:7

    Topics: Alkaline Phosphatase; Chemical and Drug Induced Liver Injury; Cholestasis; Chromans; Female; Humans; Hypoglycemic Agents; Liver Function Tests; Middle Aged; Rosiglitazone; Thiazoles; Thiazolidinediones; Transaminases; Troglitazone

2002